Literature DB >> 12740265

Left ventricular diastolic function in patients with advanced cystic fibrosis.

Todd M Koelling1, G William Dec, Leo C Ginns, Marc J Semigran.   

Abstract

OBJECTIVES: To assess left ventricular systolic and diastolic function in adult patients with cystic fibrosis using radionuclide ventriculography.
BACKGROUND: Although myocardial fibrosis has been described in autopsy specimens of patients with cystic fibrosis, the possibility that myocardial dysfunction may occur during life in adult patients with cystic fibrosis has not been explored.
METHODS: To assess the possibility of cardiac dysfunction occurring in cystic fibrosis, we studied 40 patients with advanced cystic fibrosis with first-pass radionuclide ventriculography and compared them to 9 patients with advanced bronchiectasis and 18 normal control subjects.
RESULTS: Indexes of right ventricular systolic function were similarly impaired in patients with cystic fibrosis and patients with bronchiectasis. Left ventricular ejection fraction of patients with cystic fibrosis, patients with bronchiectasis, and normal control subjects did not differ. Fractional left ventricular filling at 50% of diastole, an index of diastolic function, was significantly lower in patients with cystic fibrosis (54 +/- 13%, mean +/- SD) in comparison to patients with bronchiectasis (66 +/- 4%, p = 0.009) or normal control subjects (69 +/- 14, p = 0.0002). The contribution of atrial systole to total diastolic left ventricular filling was greater in patients with cystic fibrosis (38 +/- 18%) than in patients with bronchiectasis (21 +/- 4%, p = 0.01) or normal control subjects (25 +/- 12%, p = 0.01).
CONCLUSIONS: Patients with advanced cystic fibrosis demonstrate impaired left ventricular distensibility when compared to normal control subjects and patients with bronchiectasis. Patients with cystic fibrosis may be at risk of heart failure due to right ventricular dysfunction or left ventricular diastolic dysfunction.

Entities:  

Mesh:

Year:  2003        PMID: 12740265     DOI: 10.1378/chest.123.5.1488

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Focus on echocardiographic right ventricular strain analysis in cystic fibrosis adults without cardiovascular risk factors: a case-control study.

Authors:  Edoardo Sciatti; Enrico Vizzardi; Ivano Bonadei; Francesca Valentini; Elisa Menotti; Francesco Prati; Lucia Dallapellegrina; Marialma Berlendis; Piercarlo Poli; Rita Padoan; Marco Metra
Journal:  Intern Emerg Med       Date:  2019-05-14       Impact factor: 3.397

Review 2.  Pulmonary hypertension survival effects and treatment options in cystic fibrosis.

Authors:  Adriano R Tonelli
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

3.  The relationship between cardiac hemodynamics and exercise tolerance in cystic fibrosis.

Authors:  Erik H Van Iterson; Courtney M Wheatley; Sarah E Baker; Wayne J Morgan; Eric M Snyder
Journal:  Heart Lung       Date:  2016-04-01       Impact factor: 2.210

4.  Sphingosine 1-phosphate as a therapeutic target in heart failure: more questions than answers.

Authors:  Douglas L Mann
Journal:  Circulation       Date:  2012-04-25       Impact factor: 39.918

5.  The Coupling of Peripheral Blood Pressure and Ventilatory Responses during Exercise in Young Adults with Cystic Fibrosis.

Authors:  Erik H Van Iterson; Courtney M Wheatley; Sarah E Baker; Thomas P Olson; Wayne J Morgan; Eric M Snyder
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.